Breakthrough stem-cell transplant in China offers hope for Type 1 diabetes

Quick Summary:

At the one-year follow-up, there were no signs of complications, and the research team noted that the results met all clinical endpoints.

The patient, who had struggled with severe blood sugar fluctuations and hypoglycemia for years, saw dramatic improvements.

The team, in a paper, stated, "The clinical data met all study endpoints with no indication of transplant-related abnormalities.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaChinaMaliOman

Topics: Chinese researchers Peking University Diabetes medicine CiPSC islets Adipose tissue cells China stem cell treatment for diabetes China diabetes treatment Stem cell therapy Groundbreaking surgery Diabetes China diabetes Stem cell transplant Type 1 diabetes Chine diabetes surgery Patient success Health research Tianjin First Central Hospital Peking University Insulin production China diabetes news Chemically induced pluripotent stem cells Medical advancements Clinical study Blood sugar regulation Islet transplants Type 1 diabetes Medical milestone Cell transplants Immune rejection Diabetes cure Tianjin First Central Hospital Diabetes treatment

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-30 @ 15:38:58 (7 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 358 words

Reading Time: 2 minutes read

Sentences: 18 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22786401

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 321 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions